Department of Neurological Surgery, UMDNJ, Newark, New Jersey 07101, USA.
J Neurointerv Surg. 2010 Dec;2(4):385-9. doi: 10.1136/jnis.2010.002246. Epub 2010 Jun 24.
Ruptured intracranial aneurysms are responsible for over 90% of cases of spontaneous subarachnoid hemorrhage (SAH). Conventional digital subtraction angiography (DSA) remains the gold standard for diagnosing the source of SAH. A prospective study is presented wherein SAH patients underwent three dimensional CT angiography (CTA) prior to DSA in order to assess the specificity and sensitivity of this non-invasive modality to detect aneurysms.
179 consecutive patients with spontaneous SAH presented over 36 months, as identified by screening CT and CTA. Patients with negative CTA findings underwent DSA within 24 h of presentation. All patients who were determined to have angiographically negative SAH underwent follow-up DSA 2 weeks later.
Of the 179 patients screened by CTA, 13 (7%) were negative for aneurysms or other vascular lesions (arteriovenous malformation or dural fistula) on CTA and underwent DSA. No new lesions were identified on six vessel angiography, resulting in a 0% false negative rate (sensitivity 100%, predictive value 100%). MRI to rule out thrombosed aneurysms and repeat angiography at the 2 week follow-up were negative.
Sensitivity and specificity were higher than previously reported, suggesting that CTA may be used as an initial screening tool in lieu of DSA. Further studies are necessary to determine if CTA can supplant DSA in ruling out all forms of vascular disease in idiopathic SAH.
颅内破裂动脉瘤是自发性蛛网膜下腔出血(SAH)的主要原因,占 90%以上。传统的数字减影血管造影(DSA)仍然是诊断 SAH 来源的金标准。本研究前瞻性地对 179 例自发性 SAH 患者进行了三维 CT 血管造影(CTA)检查,以评估该非侵入性方法检测动脉瘤的特异性和敏感性。
在 36 个月内,通过筛查 CT 和 CTA 发现了 179 例连续自发性 SAH 患者。CTA 结果阴性的患者在发病后 24 小时内行 DSA 检查。所有经 CTA 确定为血管造影阴性的患者在 2 周后进行了随访 DSA。
在 179 例经 CTA 筛查的患者中,13 例(7%)在 CTA 上未见动脉瘤或其他血管病变(动静脉畸形或硬脑膜动静脉瘘),并进行了 DSA 检查。六血管造影未发现新的病变,假阴性率为 0%(敏感性 100%,预测值 100%)。磁共振成像(MRI)排除了血栓性动脉瘤,2 周后的重复血管造影也为阴性。
敏感性和特异性均高于以往报道,提示 CTA 可作为 DSA 的替代方法用于初始筛查。需要进一步研究以确定 CTA 是否可以替代 DSA 来排除特发性 SAH 中所有形式的血管疾病。